Pandemic Influenza (H1N1) Candidate Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pandemic Influenza (H1N1) Candidate Vaccine, covering 2017-05-02 to 2017-05-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children [Phase 2]